MERS-CoV Nucleoprotein Antibody (3877) - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05705
Key Product Details
Species Reactivity
MERS-CoV, SARS-CoV
Applications
ELISA, Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # 3877
Format
BSA Free
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Synthetic peptide
Specificity
Reactive with the NP of native SARS, MERS.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for MERS-CoV Nucleoprotein Antibody (3877) - BSA Free
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
0.01M PBS, pH7.2
Format
BSA Free
Preservative
0.1% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C.
Background: MERS-CoV Nucleoprotein
Long Name
Middle East Respiratory Syndrome Coronavirus Nucleoprotein
Alternate Names
MERS, MERS NC, MERS Nucleocapsid protein, MERS Nucleoprotein, MERSCoV NC, MERS-CoV NC, MERSCoV Nucleocapsid protein, MERS-CoV Nucleocapsid protein, MERSCOV Nucleoprotein, MERS-CoV Protein N, Middle East respiratory syndrome-related coronavirus, Nucleocapsid protein, Protein N
Gene Symbol
N
Additional MERS-CoV Nucleoprotein Products
Product Documents for MERS-CoV Nucleoprotein Antibody (3877) - BSA Free
Product Specific Notices for MERS-CoV Nucleoprotein Antibody (3877) - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...